跳到正文
AiSeekAiSeek
登录

公司

Ono Pharmaceutical

关注打开结构图就此提问研究这家公司

简介

总部
JP

Ono Pharmaceutical 的结构

Ono Pharmaceutical

公司

2 个关联
同行竞争与合作
关系出现时间2026
Ono Pharmaceutical公司 · 2 个关联
第 1 层

同行竞争与合作2

关系

箭头表示关系方向，可按业务类别筛选。

  • Mediar Therapeutics合作 →Ono Pharmaceutical
    公司 · Mediar Therapeutics证据 1
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-07 19:08
      Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.
      查看来源
  • Biohaven签署协议 →Ono Pharmaceutical
    公司 · Biohaven证据 1
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-08 16:00
      Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)
      查看来源
  • Biohaven合作 →Ono Pharmaceutical
    公司 · Biohaven证据 1
    事实90%
    查看证据
    • 公司披露PR Newswire news releases2026-10-08 16:00
      it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.
      查看来源

显示第 1 至 3 条，共 3 条

结论

结合来源阅读结论，展开条目查看证据。

事实证据 1
签署协议Biohaven

Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)

PR Newswire news releases · 2026-10-08 16:00

查看证据
  • 公司披露PR Newswire news releases2026-10-08 16:00
    Biohaven Ltd. together with its wholly owned subsidiaries, ("Biohaven") (NYSE: BHVN) today announced that it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. ("Ono") (TYO: 4528)
    查看来源
事实证据 1
合作Biohaven

it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.

PR Newswire news releases · 2026-10-08 16:00

查看证据
  • 公司披露PR Newswire news releases2026-10-08 16:00
    it has entered into a strategic licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd.
    查看来源
事实证据 1
合作Mediar Therapeutics

Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.

PR Newswire news releases · 2026-10-07 19:08

查看证据
  • 公司披露PR Newswire news releases2026-10-07 19:08
    Mediar is also progressing novel fibro-inflammatory targets as part of a recently announced collaboration with Ono Pharmaceutical.
    查看来源

显示第 1 至 3 条，共 3 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

暂无: 公司信号 · 财务数据 · 披露文件 · 业绩指引